Home / Knowledge Centre /

Industry Application – Sample Pack Boosts Moxatag Launch

Upon FDA approval of Moxatag, the first and only once-daily amoxicillin treatment for pharyngitis (strep throat) and/or tonsillitis, Middlebrook Pharmaceuticals sought a quality led, experienced CMO with dedicated Penicillin packaging facilities.
Rather than launching Moxatag in a 10 tablet blister pack as originally planned, Middlebrook focused on developing a physician sample pack to highlight the simplicity and convenience of once daily dosing by using a single tablet blister. Physician sample packs were nothing new to Almac, but the tablet size and the single tablet blister raised some technical challenges, all of which were overcome within a short timeframe by Almac’s specialist in-house engineering team. Almac’s expert engineering team designed and built high speed feeding equipment to fulfil product demand and devised and fabricated tooling to create a stable finished blister that was easy for physicians to retireve from the carton.
Read this article to discover Middlebrooks approach to developing Moxatag and the steps involved in developing a successful, strategic partnership with Almac to ensure a successful product launch.

View Resource
Almac Logo

Commercial Services

Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.

Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.

Learn More

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies